Novorapid and Osteomyelitis - a phase IV clinical study of FDA data

Summary:

Osteomyelitis is reported as a side effect among people who take Novorapid (insulin aspart recombinant), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Lantus, and have High blood pressure.

The phase IV clinical study analyzes which people have Osteomyelitis when taking Novorapid. It is created by eHealthMe based on reports of 24,590 people who have side effects when taking Novorapid from the FDA, and is updated regularly.

What is Novorapid?

Novorapid has active ingredients of insulin aspart recombinant. It is often used in type 1 diabetes. eHealthMe is studying from 24,730 Novorapid users. Check the latest studies of Novorapid.

What is Osteomyelitis?

Osteomyelitis (infection of bone) is found to be associated with 1,427 drugs and 1,327 conditions by eHealthMe. Check the latest studies of Osteomyelitis.

On Jul, 14, 2026

24,590 people reported to have side effects when taking Novorapid.
Among them, 34 people (0.14%) have Osteomyelitis.

Among these 34 people:

How long have people been on Novorapid when they have Osteomyelitis? *

What is the gender of people who have Osteomyelitis when taking Novorapid? *

female: 40 %
male: 60 %

What is the age of people who have Osteomyelitis when taking Novorapid? *

What are other drugs people take besides Novorapid? *

What are other side effects people have besides Osteomyelitis? *

Fever: 13 people, 38.24%
Sepsis (a severe blood infection that can lead to organ failure and death): 13 people, 38.24%
Cellulitis (infection under the skin): 8 people, 23.53%
Skin Ulcer: 8 people, 23.53%
Fatigue (feeling of tiredness): 5 people, 14.71%
Acute Myocardial Infarction (acute heart attack): 4 people, 11.76%
Foot Amputation (loss of foot): 4 people, 11.76%
Prostate Cancer Recurrent: 3 people, 8.82%
Pneumonia: 3 people, 8.82%
Pain In Jaw: 3 people, 8.82%

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 17.65%
Weight Loss: 5 people, 14.71%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 11.76%
Metastases To Bone (cancer spreads to bone): 4 people, 11.76%
Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 8.82%
Type 2 Diabetes: 3 people, 8.82%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 3 people, 8.82%
Dyspnea (difficult or laboured breathing): 3 people, 8.82%
Acute Myocardial Infarction (acute heart attack): 3 people, 8.82%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Novorapid and have Osteomyelitis?

- Check whether Osteomyelitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novorapid:

Novorapid (24,730 reports)

Osteomyelitis treatments and more:

Osteomyelitis (34,172 reports)

Browse all side effects of Novorapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteomyelitis:

Osteomyelitis (1,427 drugs)

Browse all the conditions that are associated with Osteomyelitis:

Osteomyelitis (1,327 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin aspart recombinant (the active ingredients of Novorapid) and Novorapid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.